BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12884147)

  • 1. [Tolerance induction in anaphylaxis to carboplatin].
    Herzinger T; Behr J; Przybilla B
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1595-6. PubMed ID: 12884147
    [No Abstract]   [Full Text] [Related]  

  • 2. Carboplatin desensitization.
    Keat K; Harnett P; Fulcher DA
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):468-9. PubMed ID: 18051220
    [No Abstract]   [Full Text] [Related]  

  • 3. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
    Hosaka M; Ebina Y; Moriwaki M; Hara Y; Araki N; Todo Y; Takeda M; Watari H; Sakuragi N
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1505-8. PubMed ID: 17876157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug allergy.
    Honsinger RW
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):111. PubMed ID: 15328668
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
    Enrique E; Malek T; Castelló JV; de Mateo JA
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
    [No Abstract]   [Full Text] [Related]  

  • 6. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
    Broome CB; Schiff RI; Friedman HS
    Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.
    Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M
    J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175
    [No Abstract]   [Full Text] [Related]  

  • 9. Carboplatin hypersensitivity and desensitization in an infant.
    Montiel Herrera JM; Góngora-Melendez MA; Pineda-Maldonado ML; Medina-Sanson A; Del Rio Chivardi JM; Del Río-Navarro BE; Rosas-Vargas MA
    Ther Drug Monit; 2010 Aug; 32(4):525-8. PubMed ID: 20463633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful desensitization protocol for patients with hypersensitivity reactions caused by carboplatin].
    Nishio S; Koyanagi T; Miyabe K; Kuromatsu H
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):731-3. PubMed ID: 20414037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels.
    Ojaimi S; Harnett PR; Fulcher DA
    J Allergy Clin Immunol Pract; 2014; 2(1):105-6. PubMed ID: 24565780
    [No Abstract]   [Full Text] [Related]  

  • 12. Desensitization with oxaliplatin in patients intolerant of carboplatin desensitization.
    Rose PG; Metz C; Link N
    Int J Gynecol Cancer; 2014 Nov; 24(9):1603-6. PubMed ID: 25304679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions.
    Köppler H; Heymanns J; Weide R
    Onkologie; 2001 Jun; 24(3):283-5. PubMed ID: 11455223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful carboplatin desensitization in patients with proven carboplatin allergy.
    Confino-Cohen R; Fishman A; Altaras M; Goldberg A
    Cancer; 2005 Aug; 104(3):640-3. PubMed ID: 15977213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin hypersensitivity: evaluation and successful desensitization protocol.
    Bruchim I; Goldberg A; Fishman A; Confino-Cohen R
    Immunotherapy; 2014; 6(8):905-12. PubMed ID: 25313569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis to carboplatin following multiple previous uncomplicated courses.
    Sood AK; Gelder MS; Huang SW; Morgan LS
    Gynecol Oncol; 1995 Apr; 57(1):131-2. PubMed ID: 7705695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 19. The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer management.
    Markman M
    Gynecol Oncol; 2007 Nov; 107(2):163-5. PubMed ID: 17675141
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of repeated monthly carboplatin desensitization.
    Morgan M; Bowers DC; Gruchalla RS; Khan DA
    J Allergy Clin Immunol; 2004 Oct; 114(4):974-5. PubMed ID: 15480344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.